The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Although a variant of primary biliary cirrhosis (PBC) characterized by features of autoimmune hepatitis (AIH) has been recognized for many years, few studies with ample numbers of patients have focused on its natural history. This study aimed to clarify the natural history, prognosis, and response to therapy in a cohort of patients with PBC with AIH features. We retrospectively analyzed 277 PBC patients without AIH features and 46 PBC patients with AIH features seen between September 2004 and April 2014. The 5-year adverse outcome-free survival of PBC patients with AIH features was 58% compared to 81% in PBC patients without AIH features. Multivariate analysis in the patients with AIH features indicated that total bilirubin ≥ 2.70× the upper limit of normal predicted a poor prognosis (p = 0.008, relative risk 8.39, 95% confidence interval (CI) 1.73, 40.73). Combination therapy with ursodeoxycholic acid (UDCA) and immunosuppression provided better short-term responses in PBC patients with AIH features, defined by multiple criteria. Higher aspartate aminotransferase (AST) level at accession suggested better prognosis for PBC patients with AIH features while worse prognosis for PBC patients without AIH features. PBC patients with AIH features differ from those without AIH features in terms of natural history, prognostic indicators, and response to therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prognosis of patients with PBC and features of AIH is worse than for PBC alone and patients tend to present with more advanced fibrosis [160,173,174].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [174]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 49 · Cited by 71
Metadata
- Authors
- Yang, F., Wang, Q., Wang, Z., Miao, Q., Xiao, X., Tang, R., Chen, X., Bian, Z., Zhang, H., Yang, Y., Sheng, L., Fang, J., Qiu, D., Krawitt, E. L., Gershwin, M. E., & Ma, X.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Dartmouth College (US)
- University of California, Davis (US)
- Corresponding author
- Gershwin, M. Eric
- Ma, Xiong
- ORCID
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2015-09-28
- Volume
- 50
- Issue
- 1
- Pages
- 114-123
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W1802321869
- Cited by
- 71
- References
- 49
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 2 · 2023: 8 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 8 · 2017: 13 · 2016: 5
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, natural history (disease), prognosis, total bilirubin, ursodeoxycholic acid, immunosuppression, combination therapy, aspartate aminotransferase, prognostic factors
- MeSH terms
- Adult, Autoantibodies, Biopsy, Combined Modality Therapy, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Liver, Liver Cirrhosis, Biliary, Magnetic Resonance Imaging, Male, Middle Aged, Prognosis, Risk Factors, Tomography, X-Ray Computed, Treatment Outcome, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis. https://app.cochat.ai/papers/10.1007/s12016-015-8516-5
- The paper
- Yang, F., Wang, Q., Wang, Z., Miao, Q., Xiao, X., Tang, R., Chen, X., Bian, Z., Zhang, H., Yang, Y., Sheng, L., Fang, J., Qiu, D., Krawitt, E. L., Gershwin, M. E., & Ma, X. (2016). The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-015-8516-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.